Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Grisaru

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Gynecologic Oncology|July 16, 2013
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective studyTamar Safra, Sivan Shamai, Julia Greenberg, et al.
American Journal of Obstetrics and Gynecology|January 12, 2010
Comparison of adnexal torsion between pregnant and nonpregnant womenJoseph Hasson, Ziv Tsafrir, Foad Azem, et al.
The Oncologist|August 4, 2025
Survivorship in Advanced Ovarian Cancer: A Prognostic Model for Overall Survival and Risk of RecurrenceEliya Shachar, Yael Raz, Gilat Rotkop, et al.
The Oncologist|July 14, 2020
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three-Weekly Schedule in First-Line Treatment of Ovarian CancerTamar Safra, Barliz Waissengrin, Talya Levy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responsesDan Grisaru, Marjorie Pick, Chava Perry, et al.
NPJ Vaccines|June 26, 2024
The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularitiesHadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitorsShira Peleg Hasson, Eliya Shachar, Miriam R Brezis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitorsShira Peleg Hasson, Eliya Shachar, Miriam R Brezis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 2023
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancerNadav Michaan, Atalia Wenkert, Einat Even-Sapir, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Gynecologic Oncology|July 16, 2013
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective studyTamar Safra, Sivan Shamai, Julia Greenberg, et al.
American Journal of Obstetrics and Gynecology|January 12, 2010
Comparison of adnexal torsion between pregnant and nonpregnant womenJoseph Hasson, Ziv Tsafrir, Foad Azem, et al.
The Oncologist|August 4, 2025
Survivorship in Advanced Ovarian Cancer: A Prognostic Model for Overall Survival and Risk of RecurrenceEliya Shachar, Yael Raz, Gilat Rotkop, et al.
The Oncologist|July 14, 2020
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three-Weekly Schedule in First-Line Treatment of Ovarian CancerTamar Safra, Barliz Waissengrin, Talya Levy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responsesDan Grisaru, Marjorie Pick, Chava Perry, et al.
NPJ Vaccines|June 26, 2024
The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularitiesHadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitorsShira Peleg Hasson, Eliya Shachar, Miriam R Brezis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitorsShira Peleg Hasson, Eliya Shachar, Miriam R Brezis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 2023
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancerNadav Michaan, Atalia Wenkert, Einat Even-Sapir, et al.
Pageof 9